| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |